All somatic mutations of SPOP identified in prostate cancers, including Y87C, F102C, W131G, and F133V, are situated within the MATH domain and demonstrate a dominant-negative influence on substrate binding and degradation (44, 45). This evidence concerns the gene SPOP and prostate carcinoma.